EDSANasdaqPharmaceutical PreparationsFiscal year ends September 30
Edesa Biotech, Inc.
Financials through Q3 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 13, 2026
$2.78+0.21 (+8.17%)
Close on Oct 19, 2026
- Market cap
- $25.04M
- P/E (TTM)
- –
- Dividend yield
- –
Edesa Biotech statistics
Financials through Jun 30, 2026, price as of Oct 19, 2026, median of Pharmaceutical Preparations companies for comparison
Valuation
| Measure | Edesa Biotech | Industry median |
|---|---|---|
| Market Cap | $26.80M | $166.30M |
| Enterprise Value | $16.50M | $88.19M |
| PB Ratio | 3.04 | 2.03 |
| P/TBV Ratio | 3.88 | 2.29 |
Income (trailing twelve months)
| Measure | Edesa Biotech | Industry median |
|---|---|---|
| Operating Income | -$14.63M | -$21.40M |
| Net Income | -$14.10M | -$22.46M |
| EBITDA | -$14.53M | -$16.91M |
| EPS (Diluted) | -$1.69 | -$0.83 |
Returns
| Measure | Edesa Biotech | Industry median |
|---|---|---|
| Return on Equity (ROE) | -122.9% | -53.2% |
| Return on Assets (ROA) | -102.5% | -40.9% |
| Return on Invested Capital (ROIC) | -9500.4% | -32.4% |
| Return on Capital Employed (ROCE) | -166.0% | -38.1% |
Balance sheet
| Measure | Edesa Biotech | Industry median |
|---|---|---|
| Cash & Short-Term Investments | $10.30M | $61.43M |
| Net Cash (Debt) | $10.30M | $15.35M |
| Net Cash Per Share | $1.07 | $0.66 |
| Equity (Book Value) | $8.81M | $49.09M |
| Book Value Per Share | $0.91 | $1.37 |
| Tangible Book Value | $6.91M | $23.52M |
| Working Capital | $6.87M | $76.81M |
Financial position
| Measure | Edesa Biotech | Industry median |
|---|---|---|
| Current Ratio | 2.76 | 3.34 |
| Quick Ratio | 2.63 | 2.44 |
Cash flow (trailing twelve months)
| Measure | Edesa Biotech | Industry median |
|---|---|---|
| Operating Cash Flow | -$8.91M | -$12.35M |
Efficiency
| Measure | Edesa Biotech | Industry median |
|---|---|---|
| Profits Per Employee | -$829.53K | -$703.34K |
| Employee Count | 17 | 74 |
Dividends and yields
| Measure | Edesa Biotech | Industry median |
|---|---|---|
| Earnings Yield | -52.6% | -23.3% |
| Buyback Yield | -26.9% | -0.59% |
| Shareholder Yield | -26.9% | 0.00% |
Shares
| Measure | Edesa Biotech | Industry median |
|---|---|---|
| Shares Outstanding | 9,641,030 | 58,127,000 |
| Shares Change (YoY) | 72.2% | 10.9% |
| Shares Change (QoQ) | 8.41% | 0.54% |
| Float | 5,002,340 | 49,136,700 |
| Shares Held by Insiders | 48.1% | 11.6% |
| Shares Held by Institutions | 38.9% | 59.4% |
Scores
| Measure | Edesa Biotech | Industry median |
|---|---|---|
| Altman Z-Score | -7.61 | -0.22 |
| Piotroski F-Score | 4 | 4 |
Calculated by StockData from Edesa Biotech's SEC filings and the latest closing price. Hover a measure to see its formula. The grey column is the median of companies in the same industry group (two-digit SIC code); green or red marks a better or worse value than that median.